Presentation of "N-NOSE plus pancreatic" early stage pancreatic cancer test
November 17, 2022, Tokyo, Japan - Eric di Luccio, CTO of Hirotsu Bioscience announces the company develops the pancreatic cancer screening test "N-Nose plus Pancreas" using user's urine in Tokyo on Thursday, November 17, 2022. Hirotsu Bioscience developed the new cancer specific test using genetically modifying C. elegans nematodes which react to smell of urine of patients of pancreatic cancer. (Photo by Yoshio Tsunoda/AFLO)